Skip to content

Clinical trials

Completed Neurodegenerative Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurodegenerative Diseases Status: Completed Clear all

178 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20021
20031
20042
20052
20066
20077
20084
20098
20104
201112
20127
20136
20146
20157
20167
201712
20188
201912
20207
202114
202218
20237
202410
20255

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed178

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie5
Drexel University College of Medicine5
National Institute of Environmental Health Sciences (NIEHS)5
GenSight Biologics4
National Institute of Neurological Disorders and Stroke (NINDS)4
Novartis4
Tammie L. S. Benzinger, MD, PhD4
Alkahest, Inc.3
Assistance Publique - Hôpitaux de Paris3
Central Hospital, Nancy, France3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurodegenerative Diseases178
Alzheimer Disease54
Central Nervous System Diseases44
Nervous System Diseases44
Dementia43
Parkinson Disease43
Brain Diseases38
Movement Disorders32
Cognitive Dysfunction27
Amyotrophic Lateral Sclerosis20

Trials

Showing 26 to 50 of 178. Each trial links to its page on Pharma Observatory.

78 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.